A nurse instructs the patient that if ciprofloxacin (Cipro) is taken with antacids, absorption is

A. 36 months:

This duration is longer than typical treatment courses for TB. While treatment for drug-resistant TB may require an extended duration, standard treatment for drug-sensitive TB typically lasts for a shorter period.

B. 6-12 months:

This duration is within the typical range for the treatment of drug-sensitive TB. Standard treatment regimens for drug-sensitive TB usually involve a combination of multiple antibiotics taken for 6 to 9 months, sometimes extending up to 12 months depending on factors such as the severity of the disease and the patient's response to treatment.

C. 2-4 weeks:

This duration is too short for the treatment of TB. TB treatment requires a prolonged course of antibiotics to ensure the complete eradication of the bacteria and to prevent the development of drug resistance.

D. 7-10 days:

This duration is too short for the treatment of TB. TB treatment typically lasts for several months rather than days, as it involves a combination of antibiotics taken for an extended period to effectively treat the infection.

A. The herbal product must contain only one active ingredient:

This statement is not a legal requirement contained in DSHEA. Many dietary supplements contain multiple active ingredients, such as vitamins, minerals, herbs, amino acids, and other substances. DSHEA does not mandate that dietary supplements contain only one active ingredient.

B. Effectiveness must be demonstrated by the manufacturer:

DSHEA does not require manufacturers to demonstrate the effectiveness of dietary supplements before marketing. Unlike pharmaceutical drugs, which must undergo premarket approval by the Food and Drug Administration (FDA) to demonstrate safety and efficacy, dietary supplements do not need to prove effectiveness to be marketed. Instead, manufacturers are responsible for ensuring the safety of their products and making truthful claims on product labels.

C. Dietary supplements must state that the product is not intended to diagnose, treat, cure, or prevent any disease:

This statement accurately reflects a legal requirement contained in DSHEA. Under DSHEA, dietary supplement labels must include a disclaimer stating that the product is not intended to diagnose, treat, cure, or prevent any disease. This disclaimer helps to clarify that dietary supplements are intended to support general health and well-being rather than to treat specific diseases or medical conditions.

D. Dietary supplements must be tested for safety prior to marketing:

While DSHEA requires manufacturers to ensure the safety of their dietary supplements, it does not mandate standardized premarket testing for safety by regulatory authorities. Instead, manufacturers are responsible for conducting safety assessments and ensuring that their products are safe for consumers. The FDA may take action against manufacturers if a product is found to be unsafe or if it violates regulatory requirements, but premarket testing is not a specific legal requirement under DSHEA.